Why these 4 ASX shares are ending the week in the red

The Bellamy's Australia Ltd (ASX:BAL) share price is one of four ending the week in the red. Here's why…

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

It has been quite a turnaround for the S&P/ASX 200 (Index: ^AXJO) (ASX: XJO). After a poor start to the day the benchmark index has pushed 0.3% higher to 5,914 points.

Four shares which haven't managed to climb higher today are listed below. Here's why they are ending the week in the red:

The Aconex Ltd (ASX: ACX) share price has fallen 2% to $4.67 despite there being no news out of the software-as-a-service company. But considering its shares have rallied strongly in recent weeks, today's decline is likely to be a bit of profit taking in my opinion. Investors won't have to wait long to find out if the share price gain has been justified. Aconex is due to hold its AGM on November 8.

The Bellamy's Australia Ltd (ASX: BAL) share price is down almost 3% to $11.86. Like Aconex, the infant formula and baby food company's shares have been on a tear recently. One leading broker still thinks they can go even higher, though. Yesterday Citi upgraded Bellamy's to a buy and increased its price target to $14.40.

The Clean Seas Seafood Ltd (ASX: CSS) share price has plunged 9.5% to 6.6 cents after returning to trade following its voluntary suspension. The kingfish producer has undertaken a capital raising to raise funds to support the on-going growth in Yellowtail Kingfish biomass and investment in farming and processing facilities. Approximately $7 million has been raised through institutional investors at 6 cents per share. A further $8.9 million is expected to be raised via an underwritten renounceable rights issue.

The Healthscope Ltd (ASX: HSO) share price has fallen 2.5% to $1.87 a day after its annual general meeting. Its appears as though investors were disappointed that management still expects full-year EBITDA to be flat at best in FY 2018. A drop in the New Zealand dollar overnight won't have helped either. Approximately 10% of its revenue is generated across the Tasman.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of ACONEX FPO. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »